Jolene Si Min Wong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jolene Si Min Wong has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Chin Jin Seo
Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore & Singapore General Hospital, Singapore, Singapore
2 shared publicationsClaramae S. Chia
Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore & Singapore General Hospital, Singapore, Singapore
2 shared publications- Annelies Coene
Department of Electromechanical, Systems and Metal Engineering, Ghent University, 9000 Gent, Belgium
1 shared publication Charles Rong Zhang Yau
Duke-NUS Medical School, Singapore, Singapore
1 shared publicationDarryl W. K. Juan
Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), National Cancer Centre Singapore, Singapore, Singapore
1 shared publicationEnnaliza Salazar
Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore, Singapore
1 shared publication
Latest Publications
- Top Cited Papers
- 30 November 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (2) , 1236-1247
Prehabilitation Outcomes in Surgical Oncology Patients Undergoing Major Abdominal Surgery: A Meta-analysis of Randomized Control Trials
Prehabilitation has been increasingly utilized to optimize perioperative outcomes. In this study, we aim to evaluate the impact of uni- and multimodal preh
- 30 November 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (2) , 1236-1247
Top Cited PapersPrehabilitation Outcomes in Surgical Oncology Patients Undergoing Major Abdominal Surgery: A Meta-analysis of Randomized Control Trials
Prehabilitation has been increasingly utilized to optimize perioperative outcomes. In this study, we aim to evaluate the impact of uni- and multimodal preh
- 1 December 2023
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (2) , 1205-1206
ASO Visual Abstract: Implementation of a Multidisciplinary Team and Quality of Goals of Care Discussions in Palliative Surgical Oncology Patients
- 1 December 2023
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (2) , 1205-1206
ASO Visual Abstract: Implementation of a Multidisciplinary Team and Quality of Goals of Care Discussions in Palliative Surgical Oncology Patients
- Open Access
Electromotive Enhanced Drug Administration in Oncology: Principles, Evidence, Current and Emerging Applications
Local-regional administration of cytotoxic drugs is an important adjunct to systemic chemotherapy amongst cancer patients. It allows for targeted delivery of agents at high concentration to target sites while minimizing systemic side effects. Despite the pharmacokinetic advantages of the local–regional approach, drug transport into tumor nodules remains limited due to the biophysical properties of these tissues. Electromotive enhanced drug administration (EMDA) represents a potential solution to overcome challenges in local drug transport by applying electric currents. Through electrokinetic phenomena of electromigration, electroosmosis and electroporation, electric currents have been shown to improve drug penetration and distribution in a wide variety of clinical applications. Amongst patients with non-muscular invasive bladder cancer (NMIBC) and basal and squamous cell skin cancers, EMDA has been successfully adopted and proven efficacious in several pre-clinical and clinical studies. Its application in ophthalmological and other conditions has also been explored. This review provides an overview of the underlying principles and factors that govern EMDA and discusses its application in cancer patients. We also discuss novel EMDA approaches in pre-clinical studies and explore future opportunities of developments in this field.
Open AccessElectromotive Enhanced Drug Administration in Oncology: Principles, Evidence, Current and Emerging Applications
Local-regional administration of cytotoxic drugs is an important adjunct to systemic chemotherapy amongst cancer patients. It allows for targeted delivery of agents at high concentration to target sites while minimizing systemic side effects. Despite the pharmacokinetic advantages of the local–regional approach, drug transport into tumor nodules remains limited due to the biophysical properties of these tissues. Electromotive enhanced drug administration (EMDA) represents a potential solution to overcome challenges in local drug transport by applying electric currents. Through electrokinetic phenomena of electromigration, electroosmosis and electroporation, electric currents have been shown to improve drug penetration and distribution in a wide variety of clinical applications. Amongst patients with non-muscular invasive bladder cancer (NMIBC) and basal and squamous cell skin cancers, EMDA has been successfully adopted and proven efficacious in several pre-clinical and clinical studies. Its application in ophthalmological and other conditions has also been explored. This review provides an overview of the underlying principles and factors that govern EMDA and discusses its application in cancer patients. We also discuss novel EMDA approaches in pre-clinical studies and explore future opportunities of developments in this field.